Pacer Advisors
IRWD icon

Pacer Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Pacer Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61M Sell
1,095,513
-38,999
-3% -$150K 0.01% 715
2026
Q1 		$3.98M Buy
+1,134,512
New +$4.65M 0.01% 680
2025
Q2 		– Sell
-1,789,098
Closed -$2.63M – 3506
2025
Q1 		$2.63M Sell
1,789,098
-9,941,673
-85% -$23.7M 0.01% 864
2024
Q4 		$52M Buy
11,730,771
+450,949
+4% +$1.83M 0.11% 196
2024
Q3 		$46.5M Buy
11,279,822
+2,372,183
+27% +$12.8M 0.1% 218
2024
Q2 		$58.1M Buy
8,907,639
+1,701,452
+24% +$12M 0.13% 186
2024
Q1 		$62.8M Buy
+7,206,187
New +$87.4M 0.14% 171
2023
Q3 		– Sell
-2,466,228
Closed -$26.2M – 2639
2023
Q2 		$26.2M Buy
2,466,228
+204,428
+9% +$2.2M 0.11% 199
2023
Q1 		$23.8M Buy
2,261,800
+711,756
+46% +$7.97M 0.1% 203
2022
Q4 		$19.2M Buy
1,550,044
+278,591
+22% +$3.16M 0.1% 175
2022
Q3 		$13.2M Buy
1,271,453
+338,287
+36% +$3.84M 0.09% 169
2022
Q2 		$10.8M Buy
+933,166
New +$11M 0.08% 211
2021
Q2 		– Sell
-6,889
Closed -$77K – 1478
2021
Q1 		$77K Sell
6,889
-2,506
-27% -$26.5K ﹤0.01% 1332
2020
Q4 		$107K Sell
9,395
-332
-3% -$3.63K ﹤0.01% 1358
2020
Q3 		$87K Buy
+9,727
New +$96.7K ﹤0.01% 1270
2018
Q4 		– Sell
-11,471
Closed -$177K – 791
2018
Q3 		$177K Buy
+11,471
New +$181K 0.01% 1042
2018
Q1 		– Sell
-3,501
Closed -$44K – 1086
2017
Q4 		$44K Buy
+3,501
New +$45.7K ﹤0.01% 1029

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pacer Advisors's IRWD Position: Q2 2026 in Review

Pacer Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 3.4% in Q2 2026, selling an estimated $150K and leaving 1,095,513 shares worth $4.61M. The position accounts for 0.01% of the portfolio, ranked #715.

Pacer Advisors first reported a position in IRWD in Q4 2017 and has held it in 17 quarters since. The position peaked at $62.8M in Q1 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Pacer Advisors held 1,095,513 shares of Ironwood Pharmaceuticals worth $4.61M as of Q2 2026.
  • Pacer Advisors sold 38,999 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $150K.
  • Ironwood Pharmaceuticals made up 0.01% of Pacer Advisors's portfolio in Q2 2026, its #715 holding.
  • Pacer Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2017 and has held it in 17 quarters since.
  • Pacer Advisors's Ironwood Pharmaceuticals position peaked at $62.8M in Q1 2024.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.